查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439579

全球子宫内膜消融设备市场：洞察、竞争格局、市场预测：2030 年

Endometrial Ablation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2023年全球子宫内膜消融器械市场规模为35.386亿美元。 预计到 2030 年，该市场将达到 47.195 亿美元，2024 年至 2030 年的预测期内复合年增长率为 4.95%。 子宫内膜消融设备的需求主要是由于异常阴道出血、多囊性卵巢病（PCOD）、经痛和其他妇科疾病的盛行率上升而推动的。 此外，对子宫内膜消融器械安全性的日益关注、产品开发的技术创新以及产品上市和批准的快速增加，预计也将为2024-2030年预测期内子宫内膜消融器械整体市场的增长做出贡献。

受多种因素影响，子宫内膜消融器械市场的产品需求正在成长，但主要因素之一是经痛、PCOD等妇科疾病的盛行率上升。

例如，根据美国疾病管制与预防中心 (CDC) (2023) 的数据，多囊性卵巢症候群 (PCOS) 被认为是女性不孕症的最常见原因之一。 据报道，美国每年平均有 6% 至 12% 的育龄女性患有 PCOS。

异常子宫出血（AUB）是育龄妇女最常见的疾病。 AUB 会导致生产力下降，可能需要手术介入。 据印度国家健康门户网站称，AUB 影响 9-14% 初潮至更年期的女性。 据同一来源称，每年有 17.9% 的印度女性可能受到 AUB 的影响。

因此，经期疼痛、阴道异常出血、PCOS、PCOD等妇科疾病因有效治疗而患病率不断上升，将增加对子宫内膜去除装置的需求，从而增加预测期间对子宫内膜去除装置的需求预计这将推动整体市场的成长。

本报告研究了全球子宫内膜消融设备市场，并提供了市场概述，包括按产品类型、最终用户、地区和参与市场的公司概况划分的趋势。

目录

第1章子宫内膜移除装置市场报告简介

第2章子宫内膜消融设备市场执行摘要

第3章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章子宫内膜移除装置市场主要因素分析

  • 子宫内膜消融设备市场驱动因素
  • 子宫内膜消融器械市场的限制与挑战
  • 子宫内膜消融设备市场机会

第5章子宫内膜消融器械市场波特五力分析

第6章子宫内膜移除装置市场概况

  • 依产品类型
  • 按最终用户
  • 按地区

第7章子宫内膜消融装置市场公司与产品概况

  • Medtronic
  • Johnson & Johnson Services, Inc.
  • Olympus
  • Minerva Surgical, Inc.
  • Hologic, Inc.
  • CooperSurgical Inc.
  • Richard Wolf GmbH
  • AngioDynamics
  • KARL STORZ SE & Co. KG
  • IDOMAN-MED
  • Arthrex, Inc.
  • Channel Medsystems, Inc.
  • Gynesonics
  • Boston Scientific Corporation
  • AEGEA Medical

第8章KOL浏览量

第 9 章专案方法

第 10 章关于 DelveInsight

第 11 章免责声明与联络我们

Product Code: DIMDCL0408

Endometrial Ablation Devices Market By Product Type (Cryoablation Devices, Hydrothermal Ablators, Thermal Balloon Ablator, Radiofrequency Ablators Microwave Ablators, And Others), End-User (Hospitals & Clinics, Specialty Clinics, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of gynecological disorders and the growing demand for minimally invasive surgeries across the globe

The global endometrial ablation devices market was valued at USD 3,538.60 million in 2023, growing at a CAGR of 4.95% during the forecast period from 2024 to 2030 to reach USD 4,719.50 million by 2030. The demand for endometrial ablation devices is primarily being boosted by the increasing prevalence of abnormal vaginal bleeding, polycystic ovarian disease (PCOD), menorrhagia, and other gynecological disorders. Further, the increasing focus on the safety of endometrial ablation devices and innovations in product development along with surging product launches and approvals are also contributing to the overall growth of the endometrial ablation devices market during the forecast period from 2024-2030.

Endometrial Ablation Devices Market Dynamics:

The endometrial ablation devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of gynecological disorders such as menorrhagia PCOD, and others.

For instance, according to the Centers for Disease Control and Prevention (CDC) (2023), it was stated that polycystic ovarian syndrome (PCOS) is one of the most common causes of female infertility. The source reported that each year on average 6% to 12% of women of reproductive age suffer from PCOS, in the US.

Abnormal Uterine Bleeding (AUB) is the most common disorder among reproductive-aged women. AUB causes productivity loss and may necessitate surgical intervention. As per the National Health Portal India, between menarche and menopause, AUB is claimed to affect 9 to 14% of women. As per the same source, in India, nearly 17.9% of women per year may have AUB.

Thus, the increasing prevalence of gynecological disorders such as menorrhagia, abnormal vaginal bleeding, PCOS, and PCOD will increase the demand for endometrial ablation devices owing to the effective treatment and will thereby drive the overall market growth during the forecast period.

The increasing patient preference for minimally invasive surgeries is also likely to bode well for the market growth during the forecast period. Endometrial ablation offers advantages over conventional surgeries, such as short procedure time, faster recovery, high efficiency, and lower post-treatment pain. Thus, such advantages may increase the adoption of minimally invasive treatment over the other treatment options.

The increasing developments made by the key players in the ablation segment are also contributing to the market's growth. For instance, Channel Medsystems, Inc., launched Cerene Cryotherapy Device in October 2022, for the treatment of heavy menstrual bleeding (HMB). It provides a minimally invasive endometrial ablation treatment using cooling technology (Cryoablation) that reduces menstrual bleeding and dysmenorrhea, while naturally minimizing pain without requiring general anesthesia.

Therefore, the above-mentioned factors are contributing to the growth of the endometrial ablation devices market during the forecast period from 2024-2030.

However, risks associated with endometrial ablation procedures, including infection, tearing of uterine wall, hemorrhage, and others may restrict the endometrial ablation devices market growth.

The endometrial ablation devices market experienced a period of a temporary setback as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19. The demand for endometrial ablation devices was disrupted as the treatment of gynecological disorders was classified as non-urgent and priority was given to patients suffering from covid-19 infection. Moreover, disruption in the manufacturing of devices owing to a lack of raw material and manpower, and other restrictions lead to a decreased demand for endometrial ablation devices in the market. However, with the vaccine administration and with the resumption of patients in hospitals for the treatment of gynecological disorders, the demand increased significantly in the market. Henceforth, the aforementioned factors propelled the demand for endometrial ablation devices during the pandemic and are estimated to grow similarly during the forecast period.

Endometrial Ablation Devices Market Segment Analysis:

Endometrial Ablation Devices Market by Product Type (Cryoablation devices, Hydrothermal Ablators, Thermal Balloon Ablator, Radiofrequency Ablators, Microwave Ablators, and Others), End-User (Hospitals & Clinics, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the endometrial ablation devices market, the radiofrequency ablators category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages offered by the category.

Radiofrequency ablation devices are used to transmit radio frequency energy and destroy the tissue lining the uterus. These devices ensure a reduced risk of infection. The radiofrequency ablators offer speedy treatment and recovery, higher efficacy as compared to other options, more convenience, and other advantages. Moreover, radiofrequency ablators are effective for the treatment of small cancers and offer a minimally invasive approach with no skin incisions and pain.

Apart from the advantages of the devices, the factors driving segment growth are the increasing prevalence of cervical cancer, menorrhagia, and other gynecologic disorders. According to the Global Cancer Observatory 2020, nearly 417,367 new cases of endometrial cancer were reported globally in 2020. The growing incidence of uterine cancer (endometrial cancer) worldwide is expected to increase the demand for endometrial ablation devices as the device is used to remove the tumor from the endometrial wall, thereby increasing the overall market growth.

Also, the increasing technological advancement is likely to bode well for market growth during the forecast period. For instance, in September 2021, Gynesonics received approval from the US FDA for their next-generation Sonata System 2.2 radiofrequency ablation of fibroid tumors. This Sonata technology platform integrates a commercial intrauterine ultrasound system with an advanced radiofrequency ablation device to provide incision-free, uterus-preserving treatment.

Hence, the advantages offered by radiofrequency ablators along with the rising approvals and launches are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall endometrial ablation devices market during the forecast period.

North America is expected to dominate the overall Endometrial Ablation Devices Market:

Among all the regions, North America is estimated to account for the largest share of the endometrial ablation devices market in the year 2023. Owing to the rising prevalence of gynecological disorders such as PCOS, rising incidences of abnormal uterine bleeding (AUB), menorrhagia, and escalating cases of cancer such as uterine cancer among women is driving the North America endometrial ablation devices market and is expected to witness positive growth.

For instance, the American Cancer Society estimated that about 66,200 new cases of uterus cancer will be diagnosed in the United States in 2023. Also, according to the Canadian Cancer Society (2023), it was estimated that approximately 8,100 Canadian women were diagnosed with uterine cancer in 2022. Further, the CDC (2023) reported that in 2019, menorrhagia affected more than 10 million American women each year, indicating one out of every five women having it.

The aforementioned sources stated that the prevalence of gynecological disorders is increasing in the North America region. Therefore, in such cases, endometrial ablation devices are used to remove the tumor or uterus lining, ultimately increasing the demand for endometrial ablation devices, thereby driving the regional market of endometrial ablation devices during the forecast period (2024-2030).

Coupled with the factors mentioned above, increasing strategic planning among the key players will also drive the market of endometrial ablation devices. For instance, in February 2021, CooperSurgical announced the acquisition of AEGEA Medical and its FDA-approved Mara Water Vapor Ablation system. The acquisition complemented CooperSurgical's growing portfolio of medical products that were focused on clinic and practice-based women's health. Mara is an in-office treatment that ablated the lining of the uterus in under two minutes for treatment of Heavy Menstrual Bleeding (HMB) in women.

Also, in October 2021, Hologic, announced acquiring of Bolder Surgical, for USD 160 million. The complementary acquisition of Bolder Surgical added to Hologic's surgical product line, which included the NovaSure® endometrial ablation system for the treatment of abnormal uterine bleeding, the MyoSure® tissue removal devices for the treatment of intrauterine fibroids and polyps, the Acessa® laparoscopic radiofrequency ablation system for the treatment of fibroids, among others. Thus, such strategic steps help to increase the demand for endometrial ablation devices, thereby driving the North America endometrial ablation devices market forward during the forecast period.

Endometrial Ablation Devices Market Key Players:

Some of the key market players operating in the endometrial ablation devices market include Medtronic, Johnson & Johnson Services, Inc., Olympus, Minerva Surgical, Inc., Hologic, Inc., CooperSurgical Inc., Richard Wolf GmbH, AngioDynamics, KARL STORZ SE & Co. KG, IDOMAN-MED, Arthrex, Inc., Channel Medsystems, Inc., Gynesonics, Boston Scientific Corporation, AEGEA Medical, and others.

Recent Developmental Activities in the Endometrial Ablation Devices Market:

In February 2023, Hologic announced the approval of NovaSure V5 global endometrial ablation device (GEA) in Canada and Europe, which is a minimally invasive device that emits precisely measure radio-frequency energy to safely remove the endometrium, to treat Abnormal Uterine Bleeding (AUB).

In December 2022, RF Medical received US Food and Drug Administration (FDA) approval for its MYGEN M-3004 generator and MYOBLATE radiofrequency ablation system. MYGEN M-3004 enables a combination of monopolar and bipolar modes to deliver radiofrequency energy, while MYOBLATE electrodes are intended for coagulation and ablation of soft tissue to treat fibroids in a minimally invasive manner.

In May 2020, Minerva Surgical announced the closing of the acquisition of Boston Scientific's Intrauterine Health franchise. The combined product line was aimed to treat Abnormal Uterine Bleeding (AUB). The new suite of minimally invasive tools combined the Minerva Endometrial Ablation System, the fastest-growing endometrial ablation product, with the Genesys HTA(TM) Endometrial Ablation System, for visualization within the uterine cavity during treatment.

Key Takeaways from the Endometrial Ablation Devices Market Report Study

Market size analysis for current endometrial ablation devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the endometrial ablation devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global endometrial ablation devices market.

Various opportunities available for the other competitor in the endometrial ablation devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current endometrial ablation devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for endometrial ablation devices market growth in the coming future?

Target Audience who can be benefited from this Endometrial Ablation Devices Market Report Study

Endometrial ablation devices products providers

Research organizations and consulting companies

Endometrial ablation devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in endometrial ablation devices

Various End-users who want to know more about the endometrial ablation devices market and the latest technological developments in the endometrial ablation devices market.

Frequently Asked Questions for the Endometrial Ablation Devices Market:

1. What are endometrial ablation devices?

Endometrial ablation devices are surgical devices that are used to remove a thin layer of tissue (endometrium) that lines the uterus. The devices are used for the treatment of heavy menstrual bleeding, endometrial cancer, gynecological disorders, and others.

2. What is the market for global endometrial ablation devices?

The global endometrial ablation devices market was valued at USD 3,538.60 million in 2023, growing at a CAGR of 4.95% during the forecast period from 2024 to 2030 to reach USD 4,719.50 million by 2030.

3. What are the drivers for the global endometrial ablation devices market?

The demand for endometrial ablation devices is primarily being heightened by the increasing prevalence of abnormal vaginal bleeding, polycystic ovarian disease (PCOD), menorrhagia, and other gynecological disorders. In addition, the rising demand for minimally invasive surgeries and the increasing device launches and approvals are thereby contributing to the overall growth of the endometrial ablation devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global endometrial ablation devices market?

Some of the key market players operating in the endometrial ablation devices market include Medtronic, Johnson & Johnson Services, Inc., Olympus, Minerva Surgical, Inc., Hologic, Inc., CooperSurgical Inc., Richard Wolf GmbH, AngioDynamics, KARL STORZ SE & Co. KG, IDOMAN-MED, Arthrex, Inc., Channel Medsystems, Inc., Gynesonics, Boston Scientific Corporation, AEGEA Medical, and others.

5. Which region has the highest share in the endometrial ablation devices market?

North America is expected to dominate the overall endometrial ablation devices market during the forecast period from 2024-2030. Factors such as the rising prevalence of gynecological disorders such as endometrial cancer, ovarian cancer, and others, as the rising burden of lifestyle diseases with strategic planning by the key market players such as acquisitions or mergers, are expected to drive the growth of the North American endometrial ablation devices market during the forecast period.

Table of Contents

1.Endometrial Ablation Devices Market Report Introduction

2. Endometrial Ablation Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Endometrial Ablation Devices Market Key Factors Analysis

  • 4.1. Endometrial Ablation Devices Market Drivers
    • 4.1.1. Rising prevalence of gynecological disorders
    • 4.1.2. Increasing preference for minimally invasive surgeries
  • 4.2. Endometrial Ablation Devices Market Restraints and Challenges
    • 4.2.1. Risks of post-operational complications
  • 4.3. Endometrial Ablation Devices Market Opportunities
    • 4.3.1. Increasing demand for robotic surgeries and 3-D ablation for gynecological disorders

5. Endometrial Ablation Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Endometrial Ablation Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Cryoablation Devices
    • 6.1.2. Hydrothermal Ablators
    • 6.1.3. Thermal Balloon Ablators
    • 6.1.4. Radiofrequency Ablators
    • 6.1.5. Microwave Ablators
    • 6.1.6. Others
  • 6.2. By End-User
    • 6.2.1. Hospitals & Clinics
    • 6.2.2. Specialty Clinics
    • 6.2.3. Others
  • 6.3. By Geography
    • 6.3.1. North America
      • 6.3.1.1. United States Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.1.2. Canada Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.1.3. Mexico Endometrial Ablation Devices Market Size in USD million (2021-2030)
    • 6.3.2. Europe
      • 6.3.2.1. France Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.2.2. Germany Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.2.3. United Kingdom Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.2.4. Italy Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.2.5. Spain Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.2.6. Rest of Europe Endometrial Ablation Devices Market Size in USD million (2021-2030)
    • 6.3.3. Asia-Pacific
      • 6.3.3.1. China Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.3.2. Japan Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.3.3. India Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.3.4. Australia Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.3.5. South Korea Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.3.6. Rest of Asia-Pacific Endometrial Ablation Devices Market Size in USD million (2021-2030)
    • 6.3.4. Rest of the World
      • 6.3.4.1. Middle East Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.4.2. Africa Endometrial Ablation Devices Market Size in USD million (2021-2030)
      • 6.3.4.3. South America Endometrial Ablation Devices Market Size in USD million (2021-2030)

7. Endometrial Ablation Devices Market Company and Product Profiles

  • 7.1. Medtronic
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Johnson & Johnson Services, Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Olympus
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Minerva Surgical, Inc.
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Hologic, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. CooperSurgical Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Richard Wolf GmbH
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. AngioDynamics
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. KARL STORZ SE & Co. KG
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. IDOMAN-MED
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Arthrex, Inc.
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Channel Medsystems, Inc.
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Gynesonics
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Boston Scientific Corporation
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. AEGEA Medical
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Endometrial Ablation Devices Market in Global (2021-2030)
  • Table 4: Endometrial Ablation Devices Market in Global by Product (2021-2030)
  • Table 5: Endometrial Ablation Devices Market in Global by End-User (2021-2030)
  • Table 6: Endometrial Ablation Devices Market in Global by Geography (2021-2030)
  • Table 7: Endometrial Ablation Devices Market in North America (2021-2030)
  • Table 8: Endometrial Ablation Devices Market in North America by Country (2021-2030)
  • Table 9: Endometrial Ablation Devices Market in the US (2021-2030)
  • Table 10: Endometrial Ablation Devices Market in Canada (2021-2030)
  • Table 11: Endometrial Ablation Devices Market in Mexico (2021-2030)
  • Table 12: Endometrial Ablation Devices Market in Europe (2021-2030)
  • Table 13: Endometrial Ablation Devices Market in Europe by Country (2021-2030)
  • Table 14: Endometrial Ablation Devices Market in France (2021-2030)
  • Table 15: Endometrial Ablation Devices Market in Germany (2021-2030)
  • Table 16: Endometrial Ablation Devices Market in the United Kingdom (2021-2030)
  • Table 17: Endometrial Ablation Devices Market in Italy (2021-2030)
  • Table 18: Endometrial Ablation Devices Market in Spain (2021-2030)
  • Table 19: Endometrial Ablation Devices Market in the Rest of Europe (2021-2030)
  • Table 20: Endometrial Ablation Devices Market in Asia-Pacific (2021-2030)
  • Table 21: Endometrial Ablation Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 22: Endometrial Ablation Devices Market in China (2021-2030)
  • Table 23: Endometrial Ablation Devices Market in Japan (2021-2030)
  • Table 24: Endometrial Ablation Devices Market in India (2021-2030)
  • Table 25: Endometrial Ablation Devices Market in Australia (2021-2030)
  • Table 26: Endometrial Ablation Devices Market in South Korea (2021-2030)
  • Table 27: Endometrial Ablation Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 28: Endometrial Ablation Devices Market in the Rest of the World (2021-2030)
  • Table 29: Endometrial Ablation Devices Market in RoW by Region (2021-2030)
  • Table 30: Endometrial Ablation Devices Market in the Middle East (2021-2030)
  • Table 31: Endometrial Ablation Devices Market in Africa (2021-2030)
  • Table 32: Endometrial Ablation Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Endometrial Ablation Devices Market in Global (2021-2030)
  • Figure 4: Endometrial Ablation Devices Market in Global by Product (2021-2030)
  • Figure 5: Endometrial Ablation Devices Market in Global by End-User (2021-2030)
  • Figure 6: Endometrial Ablation Devices Market in Global by Geography (2021-2030)
  • Figure 7: Endometrial Ablation Devices Market in North America (2021-2030)
  • Figure 8: Endometrial Ablation Devices Market in North America by Country (2021-2030)
  • Figure 9: Endometrial Ablation Devices Market in the US (2021-2030)
  • Figure 10: Endometrial Ablation Devices Market in Canada (2021-2030)
  • Figure 11: Endometrial Ablation Devices Market in Mexico (2021-2030)
  • Figure 12: Endometrial Ablation Devices Market in Europe (2021-2030)
  • Figure 13: Endometrial Ablation Devices Market in Europe by Country (2021-2030)
  • Figure 14: Endometrial Ablation Devices Market in France (2021-2030)
  • Figure 15: Endometrial Ablation Devices Market in Germany (2021-2030)
  • Figure 16: Endometrial Ablation Devices Market in the United Kingdom (2021-2030)
  • Figure 17: Endometrial Ablation Devices Market in Italy (2021-2030)
  • Figure 18: Endometrial Ablation Devices Market in Spain (2021-2030)
  • Figure 19: Endometrial Ablation Devices Market in the Rest of Europe (2021-2030)
  • Figure 20: Endometrial Ablation Devices Market in Asia-Pacific (2021-2030)
  • Figure 21: Endometrial Ablation Devices Market in Asia-Pacific by Country (2021-2030)
  • Figure 22: Endometrial Ablation Devices Market in China (2021-2030)
  • Figure 23: Endometrial Ablation Devices Market in Japan (2021-2030)
  • Figure 24: Endometrial Ablation Devices Market in India (2021-2030)
  • Figure 25: Endometrial Ablation Devices Market in Australia (2021-2030)
  • Figure 26: Endometrial Ablation Devices Market in South Korea (2021-2030)
  • Figure 27: Endometrial Ablation Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 28: Endometrial Ablation Devices Market in the Rest of the World (2021-2030)
  • Figure 29: Endometrial Ablation Devices Market in RoW by Region (2021-2030)
  • Figure 30: Endometrial Ablation Devices Market in the Middle East (2021-2030)
  • Figure 31: Endometrial Ablation Devices Market in Africa (2021-2030)
  • Figure 32: Endometrial Ablation Devices Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis